The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: May 2018

The secret to longevity is in the microbiome and the gut
Animal Health

The secret to longevity is in the microbiome and the gut

MAY 31, 2018
Microbiome Insights, Global Leader in Microbiome Testing, Expands to New Lab Facilities on UBC Campus
Animal Health

Microbiome Insights, Global Leader in Microbiome Testing, Expands to New Lab Facilities on UBC Campus

MAY 31, 2018
Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis
Clinical & Manufacturing

Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis

MAY 25, 2018
Project PROMISE for Clinical Research and Treatment of Metabolic Syndrome
Pharma & Human Health

Project PROMISE for Clinical Research and Treatment of Metabolic Syndrome

MAY 25, 2018
Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health
Biotics and Supplements

Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health

MAY 25, 2018
Oragenics, Inc. and Texas A&M University System Granted U.S. Patent for Lantibiotic MU1140
Infectious Disease & AMR

Oragenics, Inc. and Texas A&M University System Granted U.S. Patent for Lantibiotic MU1140

MAY 24, 2018
Management Changes at BioGaia
Finance

Management Changes at BioGaia

MAY 24, 2018
Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer
Oncology

Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer

MAY 21, 2018
Scioto Biosciences Closes $1.8M in Series A Financing
Finance

Scioto Biosciences Closes $1.8M in Series A Financing

MAY 21, 2018
New AZO Product Restores and Protects Vaginal Health
Pharma & Human Health

New AZO Product Restores and Protects Vaginal Health

MAY 17, 2018
Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children
Biotics and Supplements

Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

MAY 17, 2018